For the first time, the University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children, it said on Saturday.
The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university, NDTV reported quoting Reuters.
Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said. The two-dose Oxford/AstraZeneca vaccine has been hailed as a ‘vaccine for the world’ because it is cheaper and easier to distribute than some rivals.
AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April, the report added.
Cuttack: Odisha Vigilance sleuths on Tuesday apprehended Reshma Majhi, Assistant Revenue Inspector and In-charge Revenue…
Bhubaneswar: After Jugansu Sekhar Panda and Kalu Khandayatray, actor-turned-politician Akhil Patnaik has blasted BJP leader Aparajita…
Bhubaneswar: Ahead of the Lok Sabha and Assembly elections in Odisha, the enforcement authorities have…
Kendrapada: Hitting out at BJD leader Atanu Sabyasachi Nayak over his remarks on Haridaspur-paradip railway…
Bhubaneswar: Amid severe heatwave warning, the mercury soared past 45°C in Bhubaneswar for the first…
Sundargarh: A Special Vigilance Court has acquitted Rakesh Kumar Agarwal, a 1999 batch Odisha Administrative…
Bhubaneswar: While electioneering for twin polls in Odisha has gathered steam, the three major parties -…
New Delhi: AAP leader and Delhi Minister Saurabh Bharadwaj on Tuesday said senior party leader…